The Scientist - Home

Even as commission research budget doubles, Potocnik won't seek to increase funding directly

A challenge to the controversial crop regulation is taken to the country's highest court

New board wants to replace the contentious director Philippe Kourilsky as soon as possible

In the fall of 2003, researchers at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston were facing a problem.

If you are concerned that British science is on life support, you should worry no more. British science, it turns out, has been saved.

walking barefoot every day through a corridor of filthy, unwashed floors.

As one of the world's biggest funders of biomedical science, the Wellcome Trust can usually gather scientists to a party like honey attracts bees.

is one usually met with utter dread.

The biggest news these days in tissue microarrays (TMAs) may be that this former "next big thing" has become a standard tool for molecular profiling of disease.

The biochemical pathway that senses amino acid deficiencies in yeast is also at work in mammals, according to researchers at the University of California, Davis.

National Cancer Institute researcher Eric Huang and colleagues have identified a mechanism that promotes mutations under hypoxic conditions.

Japanese researchers have identified a sperm protein that is essential for the fusion of the sperm and egg membranes during fertilization.